Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy
Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy
批准号:
10626113
负责人:
Claudio Punzo
金额:
$41.88万
依托单位国家:
美国
项目类别:
财政年份:
2021
资助国家:
美国
项目状态:
未结题
起止时间:
2021-06-01 至 2026-05-31
关键词:
AffectAgeAge related macular degenerationAnimal ModelAreaAtrophicAutophagocytosisBlindnessCandidate Disease GeneCell DeathCellsCellular Metabolic ProcessCessation of lifeCharacteristicsComplementComplexConeDataDepositionDerivation procedureDeteriorationDiseaseDisease ProgressionDocosahexaenoic acid supplementationDrusenEcosystemElectroporationEventFRAP1 geneFatty AcidsFunctional disorderGene ExpressionGenesGenetic TranscriptionGlucoseGlycolysisGoalsHealthHexokinase 2HomeostasisHumanImpairmentIndividualIndustrializationLinkLipoproteinsLiteratureLocationLong-Term EffectsLysosomesMediatingMetabolicMetabolismModelingMusNutrientPathogenesisPathologyPathway interactionsPatientsPhasePhosphotransferasesPhotoreceptorsProceduresProcessProductionProteinsProto-Oncogene Proteins c-aktPublishingResearchRetinaRetinitis PigmentosaRodRotationSignal PathwaySignal TransductionStressStructure of retinal pigment epitheliumTestingTimeTranslationsTuberous SclerosisVertebrate Photoreceptorsadvanced diseasedensitydietarygeographic atrophyin vivolipidomicsmaculametabolomicsphotoreceptor degenerationplasmid DNApostnatalpreventresponsetranscriptome sequencingtranscriptomics
中文摘要
PI:Claudio Punzo
项目摘要
导致人类地图状萎缩(GA)的视网膜色素上皮萎缩(RPE)是视网膜色素变性的一种。
是工业化国家失明的主要原因。这是因为目前没有治疗方法
可用于预防RPE萎缩,从而防止GA,这是一种与视网膜病变相关的黄斑变性的高级形式。
变性(AMD)。该疾病的特征在于局灶性RPE细胞损失。因为RPE维持着
光感受器稳态,光感受器也死亡,然后导致失明。近日有
认识到光感受器的高代谢需求可能有助于AMD的疾病进展,
特别是因为光感受器和RPE代谢紧密相连。两个关键发现表明
光感受器在疾病发病机制中的作用一、软性玻璃疣和视网膜下玻璃疣样沉积物的分布
分别反映了锥体和杆状体的分布。这导致了一种观点,即代谢需要
是驱动存款形成的原因。第二,黄斑移位手术,
为了从垂死的RPE细胞中拯救黄斑视锥细胞而开发的新技术揭示了视锥细胞的新区域,
易位再发育GA。在这里,它被认为是高代谢需求的锥是什么原因
RPE应激。然而,是否光感受器代谢在AMD患者和非疾病之间存在差异,
个人仍然不清楚。我们最近发现,AMD患者的PR显示出营养不良的迹象,
因为它们上调与葡萄糖缺乏的适应性反应相关的基因。通过
在小鼠光感受器中模拟这种适应性反应,我们能够诱导一种病理学亚组,
这让人联想到在患有AMD的人类中看到的那些,包括局灶性RPE萎缩。该项目的目标是
确定到底是什么导致了所见的病理。我们在目标1中建议进一步分析我们的模型,
决定RPE细胞如何死亡此后,在目标2中,我们将从遗传学的角度剖析我们
已经习惯于操纵感光细胞的新陈代谢,以磨练在新陈代谢的变化,
疾病最后,在aim 3中,我们将使用代谢组学,脂质组学和转录组学来确定潜在的
基因表达的变化,导致疾病和测试推定的候选机制在体内。
这项研究的完成将有助于了解光感受器如何导致RPE萎缩。
英文摘要
PI: Claudio Punzo
Project Summary
Retinal-pigmented epithelium atrophy (RPE) that results in geographic atrophy (GA) in humans is one of the
leading causes for blindness in the industrialized world. This is because there is currently no treatment
available to prevent RPE atrophy and thus GA, which is an advanced form of Age-related Macular
Degeneration (AMD). The disease is characterized by focal RPE cell loss. Because the RPE maintains
photoreceptor homeostasis, photoreceptors die as well, which then leads to blindness. Recently, it has been
recognized that the high metabolic demands of photoreceptors may contribute to disease progression in AMD,
in particular, because photoreceptors and RPE metabolism are tightly linked. Two key findings imply
photoreceptors in disease pathogenesis. First, the distribution of soft drusen and subretinal drusenoid deposits
mirrors the distribution of cones and rods, respectively. This has led to the proposal that the metabolic needs
of photoreceptors are what drives deposit formation. Second, macular translocation procedures, which were
developed to save macular cones from dying RPE cells revealed that the new region where the cones where
translocated redeveloped GA. Here it is thought that the high metabolic demands of cones are what causes
RPE stress. However, whether photoreceptor metabolism differs between AMD patients and non-diseased
individuals remained unclear. We recently showed that PRs of AMD patients display signs of nutrient
derivation as they upregulate genes associated with an adaptive response to a glucose shortage. By
mimicking this adaptive response in mouse photoreceptors we were able to induce a subset of pathologies that
are reminiscent of those seen in humans with AMD, including focal RPE atrophy. The goal of this project is to
identify what exactly causes the pathologies seen. We propose in aim 1 to further analyze our model and to
determine how RPE cells die. Thereafter, in aim 2, we will dissect genetically the signaling pathway that we
have used to manipulate photoreceptor metabolism in order to hone in on the metabolic changes that cause
disease. Finally, in aim 3, we will use metabolomics, lipidomics and transcriptomics to identify the underlying
gene expression changes that cause disease and test putative candidate mechanisms in vivo.
Accomplishment of the proposed research will help understand how photoreceptors can cause RPE atrophy.
期刊论文(2)
专著(0)
科研奖励(0)
会议论文
DOI:
10.3390/biom11060871
发表时间:
2021-06-11
期刊:
Biomolecules
影响因子:
5.5
作者:
[Cheng SY, Malachi A, Cipi J, Ma S, Brush RS, Agbaga MP, Punzo C]
通讯作者:
Punzo C
DOI:
10.1089/hum.2022.159
发表时间:
2022-09
期刊:
HUMAN GENE THERAPY
影响因子:
4.2
作者:
[Cheng, Shun-Yun, Punzo, Claudio]
通讯作者:
Punzo, Claudio
Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy
-
批准号:10178343
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2021
-
负责人:Claudio Punzo
-
依托单位:
Identifying the cause for photoreceptor-mediated retinal-pigmented epithelium atrophy
-
批准号:10403650
-
项目类别:
-
资助金额:$40.62万
-
财政年份:2021
-
负责人:Claudio Punzo
-
依托单位:
Testing the role of Glucose deprivation during secondary cone death in Retinitis Pigmentosa
-
批准号:9919561
-
项目类别:
-
资助金额:$20.94万
-
财政年份:2019
-
负责人:Claudio Punzo
-
依托单位:
Delaying Cone Death in Retinitis Pigmentosa
-
批准号:8558356
-
项目类别:
-
资助金额:$40.98万
-
财政年份:2013
-
负责人:Claudio Punzo
-
依托单位:
Delaying Cone Death in Retinitis Pigmentosa
-
批准号:9114561
-
项目类别:
-
资助金额:$41.88万
-
财政年份:2013
-
负责人:Claudio Punzo
-
依托单位:
Delaying Cone Death in Retinitis Pigmentosa
-
批准号:8703709
-
项目类别:
-
资助金额:$41.04万
-
财政年份:2013
-
负责人:Claudio Punzo
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: